Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triferic AVNU Infusion via Freedom Pump
NCT04689932Phase 4Completed
- Sponsor
- Rockwell Medical
- Start
- Apr 2021
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ferric pyrophosphate in end stage renal disease (ESRD), sponsored by Rockwell Medical. Started Apr 2021; status: completed.
02
Drugs
ferric pyrophosphate
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT04689932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04689932.